EDEN — Eden Biosolutions Share News
0.000.00%
- £19.68m
- £18.44m
- £4.30m
RCS - Eden Biosolutions - Investor presentation
Brief: Eden Research Board Resolves To Change Company Name To Eden Biosolutions
AGM Statement
Brief: Eden Research Says US EPA Approves Expanded Label For Mevalone
US EPA approves expanded label for Mevalone
Grant of Awards under LTIP PDMR Dealing
Notice of AGM
Brief: Eden Research Reports Revenue Of £4.90 Million For 15 Months Ended 31 March 2026
Preliminary Results
Notice of Results
Brief: Eden Research Receives Regulatory Authorisation For Botrytis Fungicide In Slovakia And Egypt
Regulatory approvals in Slovakia and Egypt
Directorate change
Brief: Eden Research Expects PBT To Be 2.9 Mln Stg Loss For 15 Months To March 31, 2026
Trading Update
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company